
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $11.1M | $15.8M | $32M | $33.4M | $14.4M | |
Revenue Growth (YoY) | 6.05% | 42.58% | 102.79% | 4.5% | -56.95% | |
Cost of Revenues | $6.3M | $9.5M | $21.3M | $30.2M | $15.1M | |
Gross Profit | $4.8M | $6.3M | $10.7M | $3.3M | -$751.4K | |
Gross Profit Margin | 43.15% | 39.79% | 33.32% | 9.77% | -5.22% | |
R&D Expenses | -- | $211.1K | $941.5K | $1.4M | $586.4K | |
Selling, General & Admin | $3.9M | $7.5M | $15.2M | $12.5M | $9.7M | |
Other Inc / (Exp) | $628.8K | $756.4K | $317.1K | $2.4M | -$1.2M | |
Operating Expenses | $4.1M | $7.9M | $16.7M | $15.3M | $12M | |
Operating Income | $720.8K | -$1.6M | -$6M | -$12M | -$12.8M | |
Net Interest Expenses | $178.6K | $136.7K | $88.8K | $172.8K | $72K | |
EBT. Incl. Unusual Items | $1.2M | -$1M | -$5.8M | -$9.8M | -$14M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $1.2M | -$1M | -$5.8M | -$9.8M | -$14M | |
Minority Interest in Earnings | -- | -- | $656.2K | $2.6M | $3M | |
Net Income to Common Excl Extra Items | $1.2M | -$1M | -$5.1M | -$7.2M | -$11M | |
Basic EPS (Cont. Ops) | $1.67 | -$1.90 | -$6.70 | -$7.60 | -$11.00 | |
Diluted EPS (Cont. Ops) | $1.67 | -$1.90 | -$6.70 | -$7.60 | -$11.00 | |
Weighted Average Basic Share | $700K | $533.1K | $762.5K | $952K | $1M | |
Weighted Average Diluted Share | $700K | $533.1K | $762.5K | $952K | $1M | |
EBITDA | $1.5M | -$675.8K | -$5.1M | -$8.2M | -$12M | |
EBIT | $1.3M | -$874.3K | -$5.6M | -$9.6M | -$13.8M | |
Revenue (Reported) | $11.1M | $15.8M | $32M | $33.4M | $14.4M | |
Operating Income (Reported) | $720.8K | -$1.6M | -$6M | -$12M | -$12.8M | |
Operating Income (Adjusted) | $1.3M | -$874.3K | -$5.6M | -$9.6M | -$13.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.2M | $5.9M | $8.9M | $5.3M | $3.6M | |
Revenue Growth (YoY) | 20.28% | 83.5% | 50.82% | -40.56% | -31.54% | |
Cost of Revenues | $1.7M | $3.5M | $7.3M | $5M | $3.1M | |
Gross Profit | $1.5M | $2.4M | $1.6M | $277.3K | $537.1K | |
Gross Profit Margin | 46.39% | 41.36% | 18.13% | 5.26% | 14.87% | |
R&D Expenses | -- | $221.6K | $702.7K | $149.7K | -- | |
Selling, General & Admin | $1.3M | $3.2M | $3.1M | $2.2M | $1.7M | |
Other Inc / (Exp) | -$5.1K | -$103.4K | $570.6K | $272.4K | -$13.6K | |
Operating Expenses | $1.3M | $3.5M | $4M | $2.8M | $2.2M | |
Operating Income | $154.8K | -$1M | -$2.4M | -$2.5M | -$1.6M | |
Net Interest Expenses | $17.7K | $39.8K | $29.5K | $64.4K | -- | |
EBT. Incl. Unusual Items | $132K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $132K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Minority Interest in Earnings | -- | -- | $661.7K | $649K | -- | |
Net Income to Common Excl Extra Items | $132K | -$1.2M | -$1.2M | -$1.7M | -$1.6M | |
Basic EPS (Cont. Ops) | $0.19 | -$1.70 | -$1.20 | -$1.77 | -$1.08 | |
Diluted EPS (Cont. Ops) | $0.19 | -$1.70 | -$1.20 | -$1.77 | -$1.08 | |
Weighted Average Basic Share | $680K | $700K | $952K | $952K | $1.5M | |
Weighted Average Diluted Share | $680K | $700K | $952K | $952K | $1.5M | |
EBITDA | $196.2K | -$1.1M | -$1.6M | -$1.8M | -$1.1M | |
EBIT | $149.7K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Revenue (Reported) | $3.2M | $5.9M | $8.9M | $5.3M | $3.6M | |
Operating Income (Reported) | $154.8K | -$1M | -$2.4M | -$2.5M | -$1.6M | |
Operating Income (Adjusted) | $149.7K | -$1.2M | -$1.8M | -$2.3M | -$1.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $11.6M | $18.5M | $35M | $29.9M | $12.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $6.5M | $11.2M | $25.1M | $27.9M | $13.2M | |
Gross Profit | $5.1M | $7.2M | $9.8M | $2M | -$491.6K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $432.7K | $1.4M | $988.1K | $436.7K | |
Selling, General & Admin | $4.2M | $9.4M | $15.1M | $11.6M | $9.1M | |
Other Inc / (Exp) | $623.7K | $658.2K | $991K | $2.1M | -$1.5M | |
Operating Expenses | $4.4M | $10.1M | $17.2M | $14.2M | $11.3M | |
Operating Income | $736.6K | -$2.8M | -$7.3M | -$12.2M | -$11.8M | |
Net Interest Expenses | $135.9K | $158.8K | $78.4K | $207.7K | -- | |
EBT. Incl. Unusual Items | $1.2M | -$2.3M | -$6.4M | -$10.3M | -$13.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $1.2M | -$2.3M | -$6.4M | -$10.3M | -$13.3M | |
Minority Interest in Earnings | -- | -- | $1.3M | $2.6M | $2.3M | |
Net Income to Common Excl Extra Items | $1.2M | -$2.3M | -$5.1M | -$7.7M | -$11M | |
Basic EPS (Cont. Ops) | $1.75 | -$3.73 | -$6.20 | -$8.17 | -$10.28 | |
Diluted EPS (Cont. Ops) | $1.75 | -$3.73 | -$6.20 | -$8.17 | -$10.28 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.5M | -$1.9M | -$5.6M | -$8.5M | -$11.3M | |
EBIT | $1.4M | -$2.2M | -$6.3M | -$10M | -$13.1M | |
Revenue (Reported) | $11.6M | $18.5M | $35M | $29.9M | $12.7M | |
Operating Income (Reported) | $736.6K | -$2.8M | -$7.3M | -$12.2M | -$11.8M | |
Operating Income (Adjusted) | $1.4M | -$2.2M | -$6.3M | -$10M | -$13.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.2M | $5.9M | $8.9M | $5.3M | $3.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.7M | $3.5M | $7.3M | $5M | $3.1M | |
Gross Profit | $1.5M | $2.4M | $1.6M | $277.3K | $537.1K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $221.6K | $702.7K | $149.7K | -- | |
Selling, General & Admin | $1.3M | $3.2M | $3.1M | $2.2M | $1.7M | |
Other Inc / (Exp) | -$5.1K | -$103.4K | $570.6K | $272.4K | -$13.6K | |
Operating Expenses | $1.3M | $3.5M | $4M | $2.8M | $2.2M | |
Operating Income | $154.8K | -$1M | -$2.4M | -$2.5M | -$1.6M | |
Net Interest Expenses | $17.7K | $39.8K | $29.5K | $64.4K | -- | |
EBT. Incl. Unusual Items | $132K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $132K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Minority Interest in Earnings | -- | -- | $661.7K | $649K | -- | |
Net Income to Common Excl Extra Items | $132K | -$1.2M | -$1.2M | -$1.7M | -$1.6M | |
Basic EPS (Cont. Ops) | $0.19 | -$1.70 | -$1.20 | -$1.77 | -$1.08 | |
Diluted EPS (Cont. Ops) | $0.19 | -$1.70 | -$1.20 | -$1.77 | -$1.08 | |
Weighted Average Basic Share | $680K | $700K | $952K | $952K | $1.5M | |
Weighted Average Diluted Share | $680K | $700K | $952K | $952K | $1.5M | |
EBITDA | $196.2K | -$1.1M | -$1.6M | -$1.8M | -$1.1M | |
EBIT | $149.7K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Revenue (Reported) | $3.2M | $5.9M | $8.9M | $5.3M | $3.6M | |
Operating Income (Reported) | $154.8K | -$1M | -$2.4M | -$2.5M | -$1.6M | |
Operating Income (Adjusted) | $149.7K | -$1.2M | -$1.8M | -$2.3M | -$1.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $891.8K | $7M | $23.5M | $16.5M | $7.5M | |
Short Term Investments | -- | $3M | $1.5M | $4.5M | -- | |
Accounts Receivable, Net | -- | $5.1K | $14.2K | $80.2K | -- | |
Inventory | $936.7K | $1.8M | $4M | $4.9M | $2.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $350 | $903.8K | $882.4K | $463.2K | $196.1K | |
Total Current Assets | $1.8M | $13.1M | $29.9M | $26.6M | $10.4M | |
Property Plant And Equipment | $2.6M | $4.4M | $6.9M | $13.1M | $15.4M | |
Long-Term Investments | -- | $3.1M | $1.4M | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $4.5M | $20.6M | $38.2M | $39.8M | $25.9M | |
Accounts Payable | $799.3K | $1.2M | $2.1M | $2.4M | $2.2M | |
Accrued Expenses | $217.9K | $381.8K | $1.1M | $882.6K | $580.7K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $295.4K | $368.6K | $479.3K | $697.6K | $658.7K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.4M | $2.2M | $3.8M | $4.2M | $3.7M | |
Long-Term Debt | $499.9K | $499.9K | $499.9K | $499.9K | $499.9K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $3M | $3.9M | $5.2M | $7.8M | $6.7M | |
Common Stock | $4K | $7K | $9.5K | $9.5K | $14.9K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $1.5M | $16.7M | $28.4M | $23.5M | $19.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $4.6M | $8.5M | -- | |
Total Equity | $1.5M | $16.7M | $33M | $32M | $19.2M | |
Total Liabilities and Equity | $4.5M | $20.6M | $38.2M | $39.8M | $25.9M | |
Cash and Short Terms | $891.8K | $10M | $25M | $21M | $7.5M | |
Total Debt | $499.9K | $499.9K | $499.9K | $499.9K | $499.9K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1M | $5.1M | $21M | $16.1M | $4.9M | |
Short Term Investments | -- | $3M | $1.5M | $982.6K | -- | |
Accounts Receivable, Net | $85.6K | $5K | $625.3K | $90.9K | $198.8K | |
Inventory | $1.3M | $3.2M | $4.8M | $3.9M | $2.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.8K | $819.9K | $618.6K | $417.3K | $194.5K | |
Total Current Assets | $2.6M | $12.6M | $28.6M | $21.8M | $12.2M | |
Property Plant And Equipment | $3.6M | $4.9M | $7.4M | $14.6M | $11.3M | |
Long-Term Investments | -- | $3M | $942.7K | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $6.2M | $20.5M | $36.9M | $36.5M | $23.6M | |
Accounts Payable | $929.2K | $2M | $2.7M | $1.5M | $1.5M | |
Accrued Expenses | $214.3K | $660K | $519K | $516.1K | $738.2K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $357.3K | $377.9K | $503K | $683.5K | $551.4K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.9M | $3.1M | $3.9M | $2.9M | $3M | |
Long-Term Debt | $1.1M | $499.9K | $499.9K | $499.9K | $499.9K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.5M | $4.8M | $5.2M | $6.3M | $5.9M | |
Common Stock | $4K | $7K | $9.5K | $9.5K | $1.5K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $3.9M | $7.9M | -- | |
Total Equity | $1.7M | $15.7M | $31.7M | $30.1M | $17.7M | |
Total Liabilities and Equity | $6.2M | $20.5M | $36.9M | $36.5M | $23.6M | |
Cash and Short Terms | $1.1M | $8.1M | $22.5M | $17.1M | $4.9M | |
Total Debt | $1.1M | $499.9K | $499.9K | $499.9K | $499.9K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.2M | -$1M | -$5.8M | -$9.8M | -$14M | |
Depreciation & Amoritzation | $155.7K | $198.5K | $553.8K | $1.4M | $1.7M | |
Stock-Based Compensation | -- | $309.8K | $1.4M | $1.9M | $1.2M | |
Change in Accounts Receivable | -- | -$5.1K | -$9K | -$66K | $80.2K | |
Change in Inventories | -$232.5K | -$913.5K | -$2.2M | -$1.3M | $2.7M | |
Cash From Operations | $364.7K | -$1.9M | -$4.1M | -$6.9M | -$7M | |
Capital Expenditures | $525.2K | $1.9M | $3.4M | $5.2M | $6.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$200.5K | -$8M | -$195.6K | -$6.6M | -$1.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1M | $608.2K | -- | -- | -- | |
Long-Term Debt Repaid | -$943.4K | -- | -- | -$90.2K | -$213.7K | |
Repurchase of Common Stock | -- | -- | -- | -$21.4K | -- | |
Other Financing Activities | $346.1K | -$286.5K | -$69.5K | -$66.5K | -- | |
Cash From Financing | $512.1K | $16.1M | $20.9M | $6.8M | -$213.7K | |
Beginning Cash (CF) | $215.6K | $891.8K | $7M | $23.5M | $16.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $676.2K | $6.1M | $16.5M | -$6.7M | -$9M | |
Ending Cash (CF) | $891.8K | $7M | $23.5M | $16.8M | $7.7M | |
Levered Free Cash Flow | -$160.5K | -$3.9M | -$7.5M | -$12.1M | -$13.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $132K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Depreciation & Amoritzation | $46.5K | $80.1K | $218.3K | $425.3K | $441.7K | |
Stock-Based Compensation | -- | $224.8K | $483K | $426.3K | $56K | |
Change in Accounts Receivable | -$85.6K | $120 | -$611.2K | -$10.7K | -$198.8K | |
Change in Inventories | -$315.1K | -$1.4M | -$788.5K | $881.5K | $114.9K | |
Cash From Operations | $189.9K | -$1.1M | -$2.2M | -$1.7M | -$1.7M | |
Capital Expenditures | $443.2K | $728.4K | $744K | $2M | $828.9K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$443.3K | -$647.9K | -$243K | $1.5M | -$789.8K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $608.2K | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$2.8K | -$83.7K | -$54.8K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$150.4K | -$116.4K | -- | -- | -- | |
Cash From Financing | $457.9K | -$116.4K | -$2.8K | -$83.7K | -$54.8K | |
Beginning Cash (CF) | $891.8K | $7M | $23.5M | $16.8M | $7.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $204.5K | -$1.9M | -$2.5M | -$357.2K | -$2.6M | |
Ending Cash (CF) | $1.1M | $5.1M | $21M | $16.4M | $5.1M | |
Levered Free Cash Flow | -$253.4K | -$1.9M | -$3M | -$3.7M | -$2.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.2M | -$2.3M | -$6.4M | -$10.3M | -$13.3M | |
Depreciation & Amoritzation | $171.4K | $232.1K | $691.9K | $1.6M | $1.8M | |
Stock-Based Compensation | -- | $534.7K | $1.7M | $1.8M | $806.8K | |
Change in Accounts Receivable | -$85.6K | $80.5K | -$620.3K | $534.5K | -$108K | |
Change in Inventories | -$431.4K | -$2M | -$1.6M | $373.9K | $1.9M | |
Cash From Operations | $657.4K | -$3.3M | -$5.2M | -$6.5M | -$7M | |
Capital Expenditures | $931.1K | $2.2M | $3.4M | $6.4M | $5.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$606.4K | -$8.2M | $209.2K | -$4.9M | -$4.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.7M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$171.1K | -$184.8K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $115.8K | -$252.5K | -- | -- | -- | |
Cash From Financing | $917K | $15.5M | $21M | $6.7M | -$184.8K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $968.1K | $4M | $16M | -$4.6M | -$11.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$273.7K | -$5.5M | -$8.6M | -$12.9M | -$12.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $132K | -$1.2M | -$1.8M | -$2.3M | -$1.6M | |
Depreciation & Amoritzation | $46.5K | $80.1K | $218.3K | $425.3K | $441.7K | |
Stock-Based Compensation | -- | $224.8K | $483K | $426.3K | $56K | |
Change in Accounts Receivable | -$85.6K | $120 | -$611.2K | -$10.7K | -$198.8K | |
Change in Inventories | -$315.1K | -$1.4M | -$788.5K | $881.5K | $114.9K | |
Cash From Operations | $189.9K | -$1.1M | -$2.2M | -$1.7M | -$1.7M | |
Capital Expenditures | $443.2K | $728.4K | $744K | $2M | $828.9K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$443.3K | -$647.9K | -$243K | $1.5M | -$789.8K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $608.2K | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$2.8K | -$83.7K | -$54.8K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$150.4K | -$116.4K | -- | -- | -- | |
Cash From Financing | $457.9K | -$116.4K | -$2.8K | -$83.7K | -$54.8K | |
Beginning Cash (CF) | $891.8K | $7M | $23.5M | $16.8M | $7.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $204.5K | -$1.9M | -$2.5M | -$357.2K | -$2.6M | |
Ending Cash (CF) | $1.1M | $5.1M | $21M | $16.4M | $5.1M | |
Levered Free Cash Flow | -$253.4K | -$1.9M | -$3M | -$3.7M | -$2.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.